Table 1.
Subpopulation | Size | Phenotype | Marrow-derived epithelial cells in the lung | Reference |
---|---|---|---|---|
ELH1 | <5 μm | Lin− | Yes | [26] |
LSK2 | ND | Lin−, Sca-1+, Kit+ | No | [45] |
MAPCs3 | 8–10 μm | Flk-1+, Sca-1+, Thy-1+, CD13+, SSEA-1+ | Yes | [53] |
SSEA-14 | Lin−, CD45−, CD31+, Sca-1+, CD105+, CD73+, CD44+, vimentin+ | ND | [127] | |
VSELs5 | 2–4 μm | Lin−, Sca-1+, CD45−, SSEA-1+, Oct-4+, Nanog+ | Yes | [125] |
Ccsp6 | 5–10 μm | CD45+, CD34+, CD73+, CD90+, CD105+ | Yes | [119] |
R1/R2 CFTR7 | ND | Lin−, Sca-1+, CFTR+ | ND | [128] |
1Elutriation (E), lineage depletion (L), ability to home (H) to the BM; 2Lineage-negative (L), Sca+ (S), Kit+ (K); 3Multipotent adult progenitor cells; 4Stage-specific embryonic antigen 1; 5Very small, embryonic-like cells; 6Clara cell secretory protein; 7Cystic fibrosis transmembrane conductance regulator. ND: not determined.